related documents Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes Conferences Combined antiplatelet and anticoagulant therapy: clinical benefits and risks Conferences Factor Xa or thrombin: Is thrombin a better target? Conferences
